DNA Script

Biotechnology · Paris, France · Founded 2014 · Privately Held (backing)

Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications. DNA Script is based in Paris, France and was founded in 2014. It was valued at $660 million at its later-stage round in Jan 2022, the last priced event on record. It has raised $299 million across 1 recorded round; the latest was a $192 million Series C in Jan 2022.

PMV mark · valuation
$659.7M
Oct 2026
Priced at
its later-stage round
Jan 2022
Total raised
$298.7M
Last round
Later Stage VC (Series C)
Jan 2022
How much has DNA Script raised?
$298.7Macross 1 recorded rounds · Jan 2022 – Jan 2022

Most recently, DNA Script raised $191.7M in its Later Stage VC (Series C) (Jan 2022).

Free account
More of DNA Script with a free account
  • ·The complete investor list: 34 names
  • ·Watch DNA Script: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

DNA Script round by round

1 rounds
Jan 2022Later Stage VC (Series C)$191.7M▮
+ 1 more investors · free account

How much has DNA Script raised?

DNA Script has raised $299 million in total; 1 of its rounds is on record. The largest on record was a $192 million Series C in Jan 2022.

DNA Script investors

34 investors are on record for DNA Script, including Bpifrance, Fidelity Management & Research Company, European Commission and Coatue Management. By type, the record holds 8 venture capital firms and 4 hedge funds. The Series C in Jan 2022 drew 20 investors.

For fundraisers
Raising for a company like DNA Script?

34 investors have backed DNA Script — start your target list with the firms already writing checks in biotechnology.

See all 34 investors →

Frequently asked about DNA Script

How much has DNA Script raised?
DNA Script has raised $298.7M in total across 1 recorded funding rounds.
When was DNA Script's last funding round?
DNA Script's most recent recorded round was Later Stage VC (Series C) in Jan 2022, raising $191.7M.